Retrospective evaluation of medical information for predicting tazobactam/piperacillin-induced liver injury
{{output}}
Objective: Tazobactam/piperacillin is a first-line treatment option for hospital-acquired pneumonia; however, drug-induced liver injury (DILI) is relatively frequently observed with tazobactam/piperacillin in clinical practice. T... ...
